Results 21 to 30 of about 2,224,728 (196)

Stevens-Johnson syndrome in a child: case report and minireview

Archives of the Balkan Medical Union, 2020
Introduction. Stevens-Johnson syndrome is a rare, severe and life-threatening condition that develops mostly in response to drug use. Case presentation. We present a case of Stevens-Johnson syndrome in a boy of 11 years old, most probably developed in
Iryna CHORNOMYDZ, Oksana BOYARCHUK, Andrii CHORNOMYDZ, Natalia YAREMA, Uliana MUDRYK   +4 more
doaj   +1 more source

Stevens Johnson Syndrome/Toxic Epidermal Necrolysis and Erythema Exsudativum Multiforme [PDF]

, 2022
In the past, definition and name giving of erythema exsudativum multiforme, Stevens-Johnson syndrome and toxic epidermal necrolysis have been confusing.
Kardaun, Sylvia H., Sylvia H. Kardaun
core   +1 more source

A Case of Stevens–Johnson Syndrome in Recurrent Late-Stage Ovarian Cancer Patient after Management of Chronic Pain with Elastomeric Pump

Current Oncology, 2021
(1) Background. Stevens–Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) are severe mucocutaneous reactions, characterized by extensive necrosis and detachment of the epidermis. (2) Case presentation. We present a case of a 46-year-old patient
Andrej Cokan, Vida Gavrić Lovrec, Iztok Takač   +2 more
doaj   +1 more source

Stevens-Johnson Syndrome After Armodafinil Use [PDF]

, 2018
: We present the case of a 21-year-old woman in whom Stevens-Johnson syndrome (SJS) developed after initiation of armodafinil. Although this rare and life-threatening reaction is listed on armodafinil's label, no cases have been reported in the ...
Schmidt, Markus, Holfinger, S., Asim Roy, Roy, A., Steven Holfinger, Markus Schmidt   +5 more
core   +1 more source

Ciprofloxacin-induced Stevens-Johnson Syndrome with Grapefruit Juice Consumption: A Case Report [PDF]

, 2019
We describe the case of a 49-year-old, otherwise healthy, Hispanic male who underwent an uncomplicated vasectomy and was treated prophylactically with a one-week course of ciprofloxacin.
Sawaya, Jennifer, Sherman, Nathan, Cravens, Matthew G   +2 more
core   +1 more source

Stevens-Johnson Syndrome

, 2018
Stevens-Johnson syndrome (SJS) is an immune complex mediated hypersensitivity complex that typically involves the skin and mucous membranes.
Joya Debnath, Arpan Kumar Basak
core   +1 more source

Stevens-Johnson syndrome with vulvar involvement: A case report and literature review

Case Reports in Women's Health, 2022
Stevens-Johnson syndrome is a rare, life-threatening mucocutaneous condition causing necrosis and detachment of the epidermis. Vulvovaginal involvement, seen in up to 70% of affected women, can lead to painful chronic conditions such as adenosis ...
Jessie Hollingsworth, Selena U. Park, Veena Bhagavathi, Ashlee Green, Nancy Philips   +4 more
doaj   +1 more source

Case Report: Hydronephrosis and nephrogenic adenoma secondary to Stevens-Johnson syndrome

Frontiers in Pharmacology
IntroductionStevens–Johnson syndrome is a rare, severe cutaneous adverse reaction. There is a lack of literature reporting the complications of the bladder and ureter caused by Stevens–Johnson syndrome.
Chuan Wang, Yidong Huang
doaj   +1 more source

Stevens–Johnson syndrome following cataract surgery [PDF]

, 2015
A case of Stevens–Johnson syndrome in a healthy 58-year-old woman who underwent cataract surgery under topical anesthesia is reported. General skin erosions developed 2 hours after surgery.
Lai, Li-Ju, Hsu, Wei-Hsiu, Shen, Jen-Hsiang, Lin, Chin-Wen, Wu, Shin-Hua   +4 more
core   +1 more source

Phase II Study of Posttransplant Cyclophosphamide‐Based Graft‐Versus‐Host Disease Prophylaxis After HLA‐Mismatched Unrelated Donor Reduced Intensity Transplantation: Results From the ACCESS Trial Expansion Cohort

American Journal of Hematology, EarlyView.
ABSTRACT Posttransplant cyclophosphamide (PTCy) to prevent graft‐versus‐host disease (GVHD) improves outcomes in recipients of HLA mismatched unrelated donor (MMUD) allogeneic hematopoietic cell transplantation (allo HCT). Outcomes of MMUD HCT using PTCy in patients requiring reduced intensity or non‐myeloablative conditioning (RIC/NMA) are not well ...
Brian C. Shaffer, Monzr M. Al Malki, Antonio Martin Jimenez Jimenez, Joseph Stanek, Stephanie Bo‐Subait, Brent R. Logan, Jianqun Kou, Erin Leckrone, Heather E. Stefanski, Stephen R. Spellman, Craig Malmberg, Medhat Askar, Rachel Cusatis, Dipenkumar Modi, Farhad Khimani, Mehdi Hamadani, Martin Maiers, Rachel Cook, Karen Ballen, Javier Bolaños‐Meade, Uttam Rao, Jordan Milner, Ramzi Abboud, Katarzyna Jamieson, George Carrum, Bhagirathbhai Dholaria, William J. Hogan, Ran Reshef, Satyajit Kosuri, Alison Loren, Karilyn Larkin, Sally Arai, Muna Qayed, Sung Won Choi, Larisa Broglie, Jeffery J. Auletta, Bronwen E. Shaw, Steven M. Devine, Mahasweta Gooptu   +38 more
wiley   +1 more source